Chief Technology Officer
Current
Jan 2022 - Present
AeroLeads people directory · profile
Kee-Hong Kim, Ph.D. Email & Phone Number
Chief Technology Officer at Tenaya Therapeutics
at
Tenaya Therapeutics
1 work email found
@tenayathera.com
LinkedIn matched
✓ Verified August 2026
4 data sources
Profile completeness 100%
Current company
Role
Chief Technology Officer at Tenaya Therapeutics
Location
San Francisco Bay Area, United States
Who is Kee-Hong Kim, Ph.D.? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Kee-Hong Kim, Ph.D. is listed as Chief Technology Officer at Tenaya Therapeutics at Tenaya Therapeutics, based in San Francisco Bay Area, United States. AeroLeads shows a work email signal at tenayathera.com and a matched LinkedIn profile for Kee-Hong Kim, Ph.D..
Kee-Hong Kim, Ph.D. previously worked as Chief Technology Officer at Tenaya Therapeutics and SVP MFG/TechOps at Tenaya Therapeutics. Kee-Hong Kim, Ph.D. holds Doctor Of Philosophy (Ph.D.), Biochemical Engineering from Colorado State University.
Company email context
Email format at Tenaya Therapeutics
This section adds company-level context without repeating Kee-Hong Kim, Ph.D.'s masked contact details.
*@tenayathera.com
68% confidence
AeroLeads found 1 current-domain work email signal for Kee-Hong Kim, Ph.D.. Compare company email patterns before reaching out.
Profile bio
About Kee-Hong Kim, Ph.D.
Expert in technical operations of gene therapy biological product manufacturing
Listed skills include Biotechnology, Cell, Proteomics, Technology Transfer, and 13 others.
Current workplace
Kee-Hong Kim, Ph.D.'s current company
Company context helps verify the profile and gives searchers a useful next step.
13 roles · 26 years
Kee-Hong Kim, Ph.D. work experience
A career timeline built from the work history available for this profile.
Oct 2018 - Dec 2021
Svp, Head Of Technical Operations
Agilis Biotherapeutics Inc.
Acquired by PTC Therapeutics - Agil-AADC (UPSTAZA) approved MAA by EMACNS (Central Nervous System) gene therapy biologics
Sep 2017 - Aug 2018
Oct 2016 - Aug 2017
Feb 2016 - Sep 2016
Principal Consultant
Kds Biopharma Consulting, Llc,
• r-Baculovirus (rBV)-insect cell system PD/AD/PM for large scale cGMP manufacturing of Adeno-Associated Virus (AAV) based gene therapy, therapeutic proteins and viral vaccine • Comprehensive consulting service from DNA sequence to AAV based gene therapy drug product delivery• Lead CMC filing to regulatory agencies
Apr 2015 - Feb 2016
Director - Process Development
Avalanche Biotechnologies, Inc.
- Process Development for cGMP production of Age-Related Macular Degeneration (AMD) Gene Therapy products
Mar 2013 - Apr 2015
Cmc Project Manager
- Exclusive consultant to Avalanche Biotech, Inc.- Lead CMC filing to FDA & EMA for gene therapy biological products.- Consult process development activities for CMO & CRO.
Dec 2012 - Mar 2013
Sr. Process Development Engineer Ii
Process Development & Support PROVENGE cGMP manufacturing.
Jul 2011 - Nov 2012
Project Lead Scientist, Cell Culture Process Development
Aeras Global Tb Vaccine Foundation
Process Development for cell-culture based viral vaccines, bacterial vaccine, and other biologics cGMP manufacturing.
2009 - 2011
~2 yrs
Staff Scientist
Cpdr/Usuhs/Walter Reed Army Med. Ctr.
Human primary/immortalized cell line development and characterization
2003 - 2009
~6 yrs
Post-Doctoral Research Associate
Bacterial fermentation, proteomics, mass spectrometry
2002 - 2003
~1 yr
Post-Doctoral Fellow
Discover beta-glucosidases from Aspergillus fumigatus to produce a commercial cellulase enzyme product called CTec: (https://www.novozymes.com/en/news/news-archive/2012/02/advanced-biofuels-becoming-reality-with-novozymes-new-enzyme-technology)Published article in the Journal of Proteome Research, 2007 (http://pubs.acs.org/doi/abs/10.1021/pr070355i
2001 - 2002
~1 yr
1 education record
Kee-Hong Kim, Ph.D. education
-
Colorado State University
FAQ
Frequently asked questions about Kee-Hong Kim, Ph.D.
Quick answers generated from the profile data available on this page.
What company does Kee-Hong Kim, Ph.D. work for?
Kee-Hong Kim, Ph.D. works for Tenaya Therapeutics.
What is Kee-Hong Kim, Ph.D.'s role at Tenaya Therapeutics?
Kee-Hong Kim, Ph.D. is listed as Chief Technology Officer at Tenaya Therapeutics at Tenaya Therapeutics.
What is Kee-Hong Kim, Ph.D.'s email address?
AeroLeads has found 1 work email signal at @tenayathera.com for Kee-Hong Kim, Ph.D. at Tenaya Therapeutics.
Where is Kee-Hong Kim, Ph.D. based?
Kee-Hong Kim, Ph.D. is based in San Francisco Bay Area, United States while working with Tenaya Therapeutics.
What companies has Kee-Hong Kim, Ph.D. worked for?
Kee-Hong Kim, Ph.D. has worked for Tenaya Therapeutics, Agilis Biotherapeutics Inc., Shire, Kds Biopharma Consulting, Llc,, and Avalanche Biotechnologies, Inc..
How can I contact Kee-Hong Kim, Ph.D.?
You can use AeroLeads to view verified contact signals for Kee-Hong Kim, Ph.D. at Tenaya Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did Kee-Hong Kim, Ph.D. attend?
Kee-Hong Kim, Ph.D. holds Doctor Of Philosophy (Ph.D.), Biochemical Engineering from Colorado State University.
What skills is Kee-Hong Kim, Ph.D. known for?
Kee-Hong Kim, Ph.D. is listed with skills including Biotechnology, Cell, Proteomics, Technology Transfer, Monoclonal Antibodies, Cell Culture, Validation, and Life Sciences.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial